Publications of F. Holsboer

Holsboer, F.; Ising, M.: Central CRH system in depression and anxiety - Evidence from clinical studies with CRH1 receptor antagonists. European Journal of Pharmacology 583 (2-3), pp. 350 - 357 (2008)

Ising, M.; Depping, A.-M.; Siebertz, A.; Lucae, S.; Unschuld, P. G.; Kloiber, S.; Horstmann, S.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the FKBP5 gene region modulates recovery from psychosocial stress in healthy controls. European Journal of Neuroscience 28, pp. 389 - 398 (2008)

Steiner, M. A.; Marsicano, G.; Nestler, E. J.; Holsboer, F.; Wotjak, C. T.: Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 33 (1), pp. 54 - 67 (2008)

Steiner, M. A.; Wanisch, K.; Monory, K.; Marsicano, G.; Borroni, E.; Bächli, H.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. The Pharmacogenomics Journal 8 (3), pp. 196 - 208 (2008)

Uhr, M.; Tontsch, A.; Namendorf, C.; Ripke, S.; Lucae, S.; Ising, M.; Dose, T.; Ebinger, M.; Rosenhagen, M.; Kohli, M. et al.; Kloiber, S.; Salyakina, D.; Bettecken, T.; Specht, M.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, pp. 203 - 209 (2008)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kohli, M.; Kloiber, S.; Salyakina, D.; Thoeringer, C. K.; Kern, N.; Lieb, R. et al.; Uhr, M.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of Affective Disorders 105, pp. 177 - 184 (2008)

Kessler, M. S.; Murgatroyd, C.; Bunck, M.; Czibere, L.; Frank, E.; Jacob, W.; Horvath, C.; Muigg, P.; Holsboer, F.; Singewald, N. et al.; Spengler, D.; Landgraf, R.: Diabetes insipidus and, partially, low anxiety-related behaviour are linked to a SNP-associated vasopressin deficit in LAB mice. European Journal of Neuroscience 26 (10), pp. 2857 - 2864 (2007)

Carbia-Nagashima, A.; Gerez, J.; Perez-Castro, C.; Paez-Pereda, M.; Silberstein, S.; Stalla, G. K.; Holsboer, F.; Arzt, E.: RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1 alpha during hypoxia. Cell 131 (2), pp. 309 - 323 (2007)

Jastorff, A.; Haegler, K.; Maccarrone, G.; Holsboer, F.; Weber, F.; Turck, C.; Ziemssen, T.: Experimental autoimmune encephalomyelitis biomarkers indicate mechanisms mediating neurodegeneration. Multiple Sclerosis 13 (Suppl. 2), p. S250 - S250 (2007)

Bunck, M.; Czibere, L.; Schmidt, M. V.; Rafael, J.; Muigg, P.; Panhuysen, M.; Puetz, B.; Deussing, J. M.; Singewold, N.; Holsboer, F. et al.; Wigger, A.; Landgraf, R.: Expressing emotions: Avp and Crh are involved in the phenotype of mice bred for extremes in anxiety-related behavior. Pharmacopsychiatry 40 (5), p. 230 - 230 (2007)

Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S.; Ripke, S. et al.; Mueller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients. Pharmacopsychiatry 40 (5), p. 209 - 209 (2007)

Ising, M.; Zimmermann, U. S.; Kuenzel, H. E.; Uhr, M.; Foster, A. C.; Learned-Coughlin, S. M.; Holsboer, F.; Grigoriadis, D. E.: High-affinity CRF1 receptor antagonist NBI-34041: Preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology 32 (9), pp. 1941 - 1949 (2007)

Kirmeier, T.; Fessler, B.; Wochnik-Veltrup, G.; Kozany, C.; Kimura, M.; Hausch, F.; Uhr, M.; Turck, C.; Holsboer, F.; Rein, T.: Proteomic search for intrcellular binding sites of antidepressants. Pharmacopsychiatry 40 (5), p. 210 - 210 (2007)

Kloiber, S.; Ripke, S.; Kohli, M.; Reppermund, S.; Salyakina, D.; Bettecken, T.; Ising, M.; Uhr, M.; Horstmann, S.; Dose, T. et al.; Unschuld, P. G.; Zihl, J.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Polymorphisms in the leptin gene are associated with resistance to antidepressant treatment and lower cognitive performance in depression. Pharmacopsychiatry 40 (5), pp. 210 - 211 (2007)

Knapp, R. T.; Holsboer, F.; Rein, T.: The hsp70 cochaperones BAG-1 M and HspBP1 as possible cause for glucocorticoid resistance. Pharmacopsychiatry 40 (5), p. 245 - 245 (2007)

Kohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Lieb, R. et al.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)

Kohli, M. A.; Salyakina, D.; Lucae, S.; Ising, M.; Bettecken, T.; Ripke, S.; Uhr, M.; Kloiber, S.; Horstmann, S.; Pütz, B. et al.; Reppermund, S.; Heck, A.; Pfister, H.; Holsboer, F.; Müller-Myhsok, B.: Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)

Kronsbein, H. C.; Weber, P.; Refojo, D.; Wurst, W.; Holsboer, F.; Deussing, J. M.: Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)

Lucae, S.; Marcus, I.; Saemann, P.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M.; Kloiber, S.; Bondy, B.; Rupprecht, R. et al.; Domschke, K.; Arolt, V.; Lichtner, P.; Holsboer, F.; Müller-Myhsok, B.: Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response. Pharmacopsychiatry 40 (5), p. 213 - 213 (2007)

Nothdurfter, C.; Eisensamer, B.; Rein, T.; Rammes, G.; Uhr, M.; Henes, K.; Wagner, E. M.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels. Pharmacopsychiatry 40 (5), p. 247 - 247 (2007)